Plus Therapeutics | CYTX - Pre Tax Profit

Stock Price
5.27
Daily Change
-0.17 -3.04%
Monthly
-19.22%
Yearly
-68.65%
Q2 Forecast
4.67

Plus Therapeutics reported $-5.71M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Baxter International USD 121M 12M Sep/2025
Cerus USD -20.76M 17.9M Dec/2024
Dr.Reddys Laboratories INR 15.68B 2.38B Dec/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Starpharma Holdings AUD -2.3M 1.94M Jun/2025
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025